Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Blood|September 1, 2011
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseDavid A Jacobsohn, Mukta Arora, John P Klein, et al.
Blood|August 29, 2013
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortalityJoseph Pidala, Tao Wang, Michael Haagenson, et al.
Transplantation and Cellular Therapy|March 16, 2023
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J Auletta, Jianqun Kou, Min Chen, et al.
Scientific Reports|July 23, 2021
Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemiaYoujin Wang, Weiyin Zhou, Lisa J McReynolds, et al.
Nature Communications|September 8, 2022
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosisDerek W Brown, Weiyin Zhou, Youjin Wang, et al.
Transplantation and Cellular Therapy|July 21, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 7, 2018
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free SurvivalAmin Alousi, Tao Wang, Michael T Hemmer, et al.
Frontiers in Immunology|April 17, 2024
Donor <i>KIR</i> genotype based outcome prediction after allogeneic stem cell transplantation: no land in sightJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Transplantation and Cellular Therapy|April 21, 2022
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesRachel Phelan, Min Chen, Caitrin Bupp, et al.
Pageof 19